Articles with public access mandates - J WoolardLearn more
Not available anywhere: 1
Changes critical to persistent lowering of arterial pressure in spontaneously hypertensive rat occur early in antihypertensive treatment
TM Hale, TL Bushfield, J Woolard, JJ Pang, KJ Rees-Milton, MA Adams
Journal of hypertension 29 (1), 113-122, 2011
Mandates: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada
Available somewhere: 39
Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2
CJ Peach, VW Mignone, MA Arruda, DC Alcobia, SJ Hill, LE Kilpatrick, ...
International journal of molecular sciences 19 (4), 1264, 2018
Mandates: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Expression of pro-and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
DG Nowak, J Woolard, EM Amin, O Konopatskaya, MA Saleem, ...
Journal of cell science 121 (20), 3487-3495, 2008
Mandates: British Heart Foundation
Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis
DG Nowak, EM Amin, ES Rennel, C Hoareau-Aveilla, M Gammons, ...
Journal of Biological Chemistry 285 (8), 5532-5540, 2010
Mandates: British Heart Foundation, Cancer Research UK
The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
ES Rennel, E Waine, H Guan, Y Schüler, W Leenders, J Woolard, ...
British journal of cancer 98 (7), 1250-1257, 2008
Mandates: British Heart Foundation, Cancer Research UK
Molecular diversity of VEGF-A as a regulator of its biological activity
J Woolard, HS Bevan, SJ Harper, DO Bates
Microcirculation 16 (7), 572-592, 2009
Mandates: British Heart Foundation
Role of the renin–angiotensin–aldosterone and kinin–kallikrein systems in the cardiovascular complications of COVID-19 and long COVID
SL Cooper, E Boyle, SR Jefferson, CRA Heslop, P Mohan, GGJ Mohanraj, ...
International Journal of Molecular Sciences 22 (15), 8255, 2021
Mandates: UK Medical Research Council
Allosteric interactions at adenosine A1 and A3 receptors: new insights into the role of small molecules and receptor dimerization
SJ Hill, LT May, B Kellam, J Woolard
British journal of pharmacology 171 (5), 1102-1113, 2014
Mandates: National Health and Medical Research Council, Australia, UK Medical Research …
Real-time analysis of the binding of fluorescent VEGF165a to VEGFR2 in living cells: effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor …
LE Kilpatrick, R Friedman-Ohana, DC Alcobia, K Riching, CJ Peach, ...
Biochemical Pharmacology 136, 62-75, 2017
Mandates: UK Biotechnology and Biological Sciences Research Council
Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β1‐adrenoceptor expressed …
M Soave, LA Stoddart, A Brown, J Woolard, SJ Hill
Pharmacology research & perspectives 4 (5), e00250, 2016
Mandates: UK Medical Research Council
NanoBiT Complementation to Monitor Agonist-Induced Adenosine A1 Receptor Internalization
M Soave, B Kellam, J Woolard, SJ Briddon, SJ Hill
SLAS DISCOVERY: Advancing the Science of Drug Discovery 25 (2), 186-194, 2020
Mandates: UK Medical Research Council
Real-time ligand binding of fluorescent VEGF-A isoforms that discriminate between VEGFR2 and NRP1 in living cells
CJ Peach, LE Kilpatrick, R Friedman-Ohana, K Zimmerman, MB Robers, ...
Cell chemical biology 25 (10), 1208-1218. e5, 2018
Mandates: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Ligand-directed covalent labelling of a GPCR with a fluorescent tag in live cells
LA Stoddart, ND Kindon, O Otun, CR Harwood, F Patera, DB Veprintsev, ...
Communications biology 3 (1), 722, 2020
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Complex formation between VEGFR2 and the β2-adrenoceptor
LE Kilpatrick, DC Alcobia, CW White, CJ Peach, JR Glenn, K Zimmerman, ...
Cell Chemical Biology 26 (6), 830-841. e9, 2019
Mandates: Australian Research Council, National Health and Medical Research Council …
Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms
J Woolard, W Vousden, SJ Moss, A Krishnakumar, MVR Gammons, ...
Chemical Science 2 (2), 273-278, 2011
Mandates: US National Institutes of Health, German Research Foundation, British Heart …
A perspective on studying G-protein–coupled receptor signaling with resonance energy transfer biosensors in living organisms
J van Unen, J Woolard, A Rinken, C Hoffmann, SJ Hill, J Goedhart, ...
Molecular pharmacology 88 (3), 589-595, 2015
Mandates: US National Institutes of Health, UK Medical Research Council
Visualizing ligand binding to a GPCR in vivo using NanoBRET
DC Alcobia, AI Ziegler, A Kondrashov, E Comeo, S Mistry, B Kellam, ...
Iscience 6, 280-288, 2018
Mandates: US National Institutes of Health, National Health and Medical Research …
Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats
JJ Carter, LV Fretwell, J Woolard
The FASEB Journal 31 (3), 1193, 2016
Mandates: UK Biotechnology and Biological Sciences Research Council
Monitoring allosteric interactions with CXCR4 using NanoBiT conjugated nanobodies
M Soave, R Heukers, B Kellam, J Woolard, MJ Smit, SJ Briddon, SJ Hill
Cell Chemical Biology 27 (10), 1250-1261. e5, 2020
Mandates: Netherlands Organisation for Scientific Research, UK Medical Research …
Probe dependence of allosteric enhancers on the binding affinity of adenosine A1‐receptor agonists at rat and human A1‐receptors measured using NanoBRET
SL Cooper, M Soave, M Jörg, PJ Scammells, J Woolard, SJ Hill
British Journal of Pharmacology 176 (7), 864-878, 2019
Mandates: British Heart Foundation, UK Medical Research Council
Publication and funding information is determined automatically by a computer program